Stratwell Services image

Our B2B Products

Our B2B Products

Our B2B Products

Our products

ViaDerma's product pipeline is built on the clinical strength of the patented SkinPass™ technology

ViaDerma's product pipeline is built on the clinical strength of the patented SkinPass™ technology

SkinPass™ technology fuels our entire family of topical solutions. Because this delivery platform is both patented and versatile, we have engineered a vast portfolio of specialized medicines designed to bypass the epidermal barrier and deliver institutional-grade healing directly to the source of infection or inflammation.

SkinPass™ technology fuels our entire family of topical solutions. Because this delivery platform is both patented and versatile, we have engineered a vast portfolio of specialized medicines designed to bypass the epidermal barrier and deliver institutional-grade healing directly to the source of infection or inflammation.

buy vitastem

VitaStem®
Topical Antibiotic.
Our flagship product.

buy vitastem

VitaStem® Topical Antibiotic. Our flagship product.

Deep Dermal Delivery: Penetrates outer skin barriers to eliminate bacteria deep within the tissue, not just on the surface.


Broad-Spectrum Efficacy: Clinically shown to kill >99.0% of bacteria in 60 seconds, including MRSA, MSSA, and P. aeruginosa.


FDA-Listed Formula: Doctor-formulated for rapid healing across acute wounds, burns, and chronic diabetic ulcers.

ViaDerma Pilot
ViaDerma Pilot

Instructions for Use

Four-Step Instruction.

Four-Step Instruction.
Three times daily.

01

Apply directly

Apply as droplets directly to the wound bed. Use enough to cover the affected tissue.

02

Massage in lightly

With clean, gloved hands, lightly massage the solution into the tissue.

03

Cover if needed

Cover with dressing for protected sites. Leave open for hot spots and superficial lesions.

04

Three times daily

Repeat application three times daily until full healing.

Powered by SkinPass™

Patented Faster Absorption
and Penetration

Deeper, faster delivery for topical medications — throughout the entire lesion.

01 Penetrates Skin Barrier

02 Targets Entire Infection

03 Creates Protective Barrier

Powered by SkinPass™

Patented Faster Absorption
and Penetration

Deeper, faster delivery for topical medications — throughout the entire lesion.

01 Penetrates Skin Barrier

02 Targets Entire Infection

03 Creates Protective Barrier

Intellectual Property

A Protected Global Patent

Our technology is anchored by a robust and expanding intellectual property portfolio.

U.S. Patent No. 12,465,567: Awarded in 2025, this covers our "Enhanced Antibiotic and Drug Delivery" for both human and veterinary applications.

Strategic Exclusivity: Our portfolio includes 20 additional Continuation-in-Part (CIP) patent applications, establishing Via Pellé’s dominance in the transdermal delivery landscape.

Our technology is anchored by a robust and expanding intellectual property portfolio.

U.S. Patent No. 12,465,567: Awarded in 2025, this covers our "Enhanced Antibiotic and Drug Delivery" for both human and veterinary applications.

Strategic Exclusivity: Our portfolio includes 20 additional Continuation-in-Part (CIP) patent applications, establishing Via Pellé’s dominance in the transdermal delivery landscape.

CTA Image

Learn more on a call with a specialist

Schedule a free consultation with our sales team representative and discover how Via Pellé can bring innovation into your medical facility

CTA Image

Learn more on a call with a specialist

Schedule a free consultation with our sales team representative and discover how Via Pellé can bring innovation into your medical facility

CTA Image

Learn more on a call with a specialist

Schedule a free consultation with our sales team representative and discover how Via Pellé can bring innovation into your medical facility